Company

ONCOLYTICS BIOTECH INC (ONCY)

Standardized SEC financial data for ONCOLYTICS BIOTECH INC — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0001129928 · NASDAQ · Pharmaceutical Preparations.

Return on equity

-530.0%

Income statement

C$	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
R&D expense	C$12.9M	C$12.9M	C$15.4M	C$17.7M	C$21.6M	—
SG&A expense	C$12.5M	C$13.3M	C$11.5M	C$16.1M	C$13.3M	—
Net income	-C$22.5M	-C$26.3M	-C$24.8M	-C$27.8M	-C$31.7M	—

Standardized from ONCOLYTICS BIOTECH INC's SEC filings — per-share figures split-adjusted. Full history via the API.

Balance sheet

C$	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Total assets	C$34.3M	C$45.9M	C$37.3M	C$38.8M	C$20.2M	—
Total liabilities	C$9.6M	C$9.8M	C$10.8M	C$11.3M	C$14.2M	—
Retained earnings	-C$367.1M	-C$393.4M	-C$418.3M	-C$446.0M

Get ONCY data via API

# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/ONCY/financials \
  -H "X-API-Key: YOUR_KEY"

# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/ONCY/income-statement?format=csv" \
  -H "X-API-Key: YOUR_KEY"

Get a free API key Use with Claude (MCP) →View ONCY filings on SEC EDGAR →